newsfilter
← Latest News
PR Newswire·

Arcellx to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 2, 2023 /PRNewswire/ -- Arcellx, Inc. (NASDAQ:ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other